World's first soluble dual insulin injection sino and Jia® launched in China

China is a major diabetes country, according to the International Diabetes Alliance (IDF), the prevalence of diabetes in China as high as 10.9%, the number of patients more than 121 million, the highest in the world, but China's diabetes diabetes blood sugar rate is only 15.8%With the progression of type 2 diabetes, diabetics need to supplement the topical insulin therapy, but the initial insulin treatment of diabetes in China is generally late, the proportion of insulin use is low, is not conducive to protecting beta cell function to improve endogenous insulin secretion functionDegumen winter double insulin once a day with the main meal injection for insulin start-up therapy, can take into account fasting and post-meal blood glucose control, effectively reduce HbA1c, low blood sugar risk is lower; In addition, as a new generation of insulin analogues, Novo and Jia® matching injection devices are also a new generation of pre-filled injection pens developed by Novo Nordisk, which is filled with ® pen, further enhancing the ease of useNote: The original article has a cut
original title: "Focus" the world's first soluble double insulin injection listed in China